4
Changes in Ownership
Foghorn Therapeutics Inc. Filed Acc 0001562180-22-007379
Options or other derivatives
- Director acquired 32,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Lynch Thomas J. Jr. Director | 2022-10-27 | Grant or award · Stock Options (Right to buy) | +32,000 | $8.23 | $263,360 | 32,000 | D |
Loading xslF345X03/primarydocument.xml…